TWO SIGMA ADVISERS, LP - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$58,942,000
+150.4%
1,272,213
+31.8%
0.15%
+149.2%
Q1 2019$23,537,000
+214.9%
965,413
+84.1%
0.06%
+195.0%
Q4 2018$7,474,000
-27.3%
524,513
-22.5%
0.02%
-20.0%
Q3 2018$10,284,000
-43.2%
676,600
-37.3%
0.02%
-49.0%
Q2 2018$18,118,000
-15.7%
1,079,713
-18.0%
0.05%
-15.5%
Q1 2018$21,482,000
+37.7%
1,316,313
+8.0%
0.06%
+38.1%
Q4 2017$15,606,000
-8.9%
1,219,240
-12.4%
0.04%
-14.3%
Q3 2017$17,123,000
+727.2%
1,392,093
+462.9%
0.05%
+600.0%
Q2 2017$2,070,000
-44.2%
247,300
-40.4%
0.01%
-41.7%
Q1 2017$3,712,000
+195.3%
415,249
+190.4%
0.01%
+140.0%
Q4 2016$1,257,000
-25.6%
143,013
-42.9%
0.01%
-28.6%
Q3 2016$1,690,000
+93.1%
250,413
+1.9%
0.01%
+75.0%
Q2 2016$875,000
-18.8%
245,713
-32.8%
0.00%
-33.3%
Q1 2016$1,078,000
-31.4%
365,413
-1.9%
0.01%
-33.3%
Q4 2015$1,571,000
-16.2%
372,313
-4.9%
0.01%
-25.0%
Q3 2015$1,874,000
-53.1%
391,513
-29.4%
0.01%
-61.3%
Q2 2015$3,999,000
+179.5%
554,647
+185.7%
0.03%
+181.8%
Q1 2015$1,431,000
+306.5%
194,113
+160.5%
0.01%
+266.7%
Q4 2014$352,000
+130.1%
74,513
+130.6%
0.00%
+200.0%
Q1 2014$153,000
-37.8%
32,313
-33.7%
0.00%
-50.0%
Q4 2013$246,00048,7130.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders